Skip to Main Content
Skip Nav Destination

Issues

Acta Haematologica 2025, Vol. 148, No. 2

Original Paper

Subject Area: Hematology , Oncology
Acta Haematol (2025) 148 (2): 135–147. https://doi.org/10.1159/000539127
Subject Area: Hematology , Oncology
Acta Haematol (2025) 148 (2): 148–162. https://doi.org/10.1159/000538836
Subject Area: Hematology , Oncology
Acta Haematol (2025) 148 (2): 163–179. https://doi.org/10.1159/000539435
Subject Area: Hematology , Oncology
Acta Haematol (2025) 148 (2): 180–197. https://doi.org/10.1159/000539587
Subject Area: Hematology , Oncology
Acta Haematol (2025) 148 (2): 198–207. https://doi.org/10.1159/000539880

Methods

Subject Area: Hematology , Oncology
Acta Haematol (2025) 148 (2): 208–219. https://doi.org/10.1159/000539541

Brief Report

Subject Area: Hematology , Oncology
Acta Haematol (2025) 148 (2): 220–225. https://doi.org/10.1159/000540239

Patient Reported Outcomes

Subject Area: Hematology , Oncology
Acta Haematol (2025) 148 (2): 226–232. https://doi.org/10.1159/000539448
Subject Area: Hematology , Oncology
Acta Haematol (2025) 148 (2): 233–243. https://doi.org/10.1159/000539756

Conference Report

Subject Area: Hematology , Oncology
Acta Haematol (2025) 148 (2): 244–246. https://doi.org/10.1159/000544847

Pharma News

Subject Area: Hematology , Oncology
Acta Haematol (2025) 148 (2): 247–248. https://doi.org/10.1159/000545119

or Create an Account

Close Modal
Close Modal